Published on 3/26/2020 in the Prospect News Structured Products Daily.
New Issue: UBS prices $200,000 return optimization securities linked to MetLife
New York, March 26 – UBS AG, London Branch priced $200,000 of return optimization securities due March 31, 2021 linked to the common stock of MetLife, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
If MetLife stock closes at or above the initial price, the payout at maturity will be par plus 1.5 times any gain in common stock of MetLife capped at 66.98%.
Investors will share in any losses.
UBS Financial Services Inc. and UBS Investment Bank are the underwriters.
| Issuer: | UBS AG, London Branch
|
| Issue: | Return optimization securities
|
| Underlying stock: | MetLife, Inc. (NYSE: MET)
|
| Amount: | $200,000
|
| Maturity: | March 31, 2021
|
| Coupon: | 0%
|
| Price: | Par of $10
|
| Payout at maturity: | Par plus 1.5 times any gain in common stock of MetLife, capped at 66.98%; otherwise, exposure to any losses
|
| Initial share price: | $32.53
|
| Pricing date: | March 26
|
| Settlement date: | March 30
|
| Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
| Fees: | 1.5%
|
| Cusip: | 90289E631
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
